Target intelligence / Profile preview

Invariant chain–MHC class II complex (Ii–MHC II complex)

Target
Ii–MHC II complex
Molecular classification
Chaperone protein complex, Receptor complex, Immune system supermolecular assembly, Antigen presentation machinery
01

Overview

The *invariant chain–MHC class II complex* is a transient, intracellular assembly crucial for the biosynthesis and antigen-presenting function of MHC class II molecules. The invariant chain (CD74) binds to newly synthesized MHC class II α/β heterodimers in the endoplasmic reticulum, forms trimers that interact with three MHC II dimers, and blocks the peptide-binding groove to prevent premature loading of endogenous antigens[1][3][4]. This complex facilitates the proper folding of MHC II, directs its trafficking to endosomal compartments, and undergoes proteolytic degradation releasing the CLIP fragment, which is subsequently replaced by antigenic peptides before transport and display on the cell surface for recognition by CD4+ T cells[1][3][4][6]. Disruption or targeting of the invariant chain–MHC II complex has biomedical significance in modulating immune responses, treating autoimmune diseases, and cancer immunotherapy[6][4].

Other names
CD74–MHC class II complexInvariant chain–class II complexIi–MHC II complexClass II–Ii nonamerMHC class II–CLIP complex
02

Mechanism of action

Antibody-mediated inhibition/blockade of CD74/invariant chain leading to immune modulation, apoptosis in certain cancers, and interference with antigen presentation Immune cell depletion or modulation of antigen presentation by preventing MHC class II surface expression or function

03

Biological functions

Chaperoning MHC class II folding and assemblyBlocking premature peptide binding to MHC IIDirecting MHC II complex to endosomal/lysosomal compartmentsRegulating peptide exchange for antigen presentationModulation of antigen presentation to CD4+ T cells
04

Disease associations

Autoimmune diseasesCancerInfectionInflammationOther immunodeficiency disorders
05

Safety considerations

Potential immune suppression—inhibition of invariant chain–MHC II may compromise antigen presentation and increase infection riskOff-target immune consequences due to pervasive expression of CD74/invariant chain in normal immune cellsCytokine release and inflammatory risks from disturbing antigen presentationTumor escape if antigen presentation is excessively reduced
06

Interacting drugs

Milatuzumab

1 more in the full profile.

07

Biomarkers

CD74 (invariant chain) expression on B cells, dendritic cells, some T cells and tumors (as a diagnostic/prevalence marker)HLA-DR surface expression (to help characterize antigen presentation competency)

Beyond the preview

Go deeper on Invariant chain–MHC class II complex (Ii–MHC II complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invariant chain–MHC class II complex (Ii–MHC II complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call